Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 23, 2023, Tram Tran, M.D. notified Arbutus Biopharma Corporation (the
"Company") of her decision to resign from the Board of Directors of the Company
and all committees thereof, effective as of February 26, 2023. The resignation
of Dr. Tran is not due to any disagreement with the Company on any matter
relating to the Company's operations, policies or practices.
A copy of the Company's press release announcing Dr. Tran's resignation
effective as of February 26, 2023, is filed herewith as Exhibit 99.1 and is
incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description
99.1 Press Release dated January 27, 2023
104 Cover Page Interactive Data File (embedded within the Inline
XBRL document)
© Edgar Online, source Glimpses